DK2240017T3 - Ketonlegemer og ketonlegemsestere som blodlipid-sænkende midler - Google Patents
Ketonlegemer og ketonlegemsestere som blodlipid-sænkende midler Download PDFInfo
- Publication number
- DK2240017T3 DK2240017T3 DK09701051.6T DK09701051T DK2240017T3 DK 2240017 T3 DK2240017 T3 DK 2240017T3 DK 09701051 T DK09701051 T DK 09701051T DK 2240017 T3 DK2240017 T3 DK 2240017T3
- Authority
- DK
- Denmark
- Prior art keywords
- ketonleges
- cetonle
- customers
- blood lipid
- lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1896208P | 2008-01-04 | 2008-01-04 | |
| PCT/US2009/030095 WO2009089144A1 (en) | 2008-01-04 | 2009-01-05 | Ketone bodies and ketone body esters as blood lipid lowering agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2240017T3 true DK2240017T3 (da) | 2019-06-17 |
Family
ID=40853425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09701051.6T DK2240017T3 (da) | 2008-01-04 | 2009-01-05 | Ketonlegemer og ketonlegemsestere som blodlipid-sænkende midler |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9211275B2 (da) |
| EP (1) | EP2240017B1 (da) |
| CN (2) | CN106038532B (da) |
| AU (1) | AU2009204370B2 (da) |
| DK (1) | DK2240017T3 (da) |
| ES (1) | ES2730879T3 (da) |
| TR (1) | TR201908522T4 (da) |
| WO (1) | WO2009089144A1 (da) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1648952T3 (da) | 2003-06-03 | 2018-05-28 | The Us Gov As Represented By The Department Of Health And Human Services | Kosttilskud og terapeutiske sammensætninger omfattende (R)-3-hydroxybutyrat-derivater |
| WO2009089144A1 (en) | 2008-01-04 | 2009-07-16 | Isis Innovation Limited | Ketone bodies and ketone body esters as blood lipid lowering agents |
| US8642654B2 (en) | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| GB201002983D0 (en) | 2010-02-22 | 2010-04-07 | Tdeltas Ltd | Nutritinal composition |
| WO2014071389A1 (en) | 2012-11-05 | 2014-05-08 | Veech Richard L | Ketone bodies to protect tissues from damage by ionizing radiation |
| GB201304467D0 (en) | 2013-03-12 | 2013-04-24 | Tdeltas Ltd | Compound for use in protecting skin |
| GB2515603B (en) | 2013-03-14 | 2015-10-14 | Isis Innovation | Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate |
| BR112015024186B1 (pt) * | 2013-03-19 | 2023-05-09 | University Of South Florida | Composições e métodos para produção de cetose de elevação e manutenção |
| US20150199491A1 (en) * | 2014-01-10 | 2015-07-16 | Critical Care Diagnostics, Inc. | Methods and systems for determining risk of heart failure |
| JP6721583B2 (ja) | 2014-07-21 | 2020-07-15 | オウルン イリオピストＯｕｌｕｎ Ｙｌｉｏｐｉｓｔｏ | ３−ヒドロキシブチラートのオリゴマー体 |
| CN104940181B (zh) * | 2015-06-29 | 2018-02-16 | 齐锦生 | β‑羟丁酸或其药学上可接受的盐的用途 |
| US11241403B2 (en) | 2016-03-11 | 2022-02-08 | Axcess Global Sciences, Llc | Beta-hydroxybutyrate mixed salt compositions and methods of use |
| US10292952B2 (en) | 2016-03-11 | 2019-05-21 | Axcess Global Sciences, Llc | Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis |
| US10245243B1 (en) | 2017-12-19 | 2019-04-02 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use |
| US11103470B2 (en) | 2017-11-22 | 2021-08-31 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10596131B2 (en) | 2017-11-22 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10245242B1 (en) | 2017-11-22 | 2019-04-02 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10973786B2 (en) | 2016-03-11 | 2021-04-13 | Axcess Global Sciences, Llc | R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions |
| US10596129B2 (en) | 2017-11-22 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10736861B2 (en) | 2016-03-11 | 2020-08-11 | Axcess Global Sciences, Llc | Mixed salt compositions for producing elevated and sustained ketosis |
| US10973792B2 (en) | 2019-02-13 | 2021-04-13 | Axcess Global Sciences, Llc | Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use |
| US11185518B2 (en) | 2017-12-19 | 2021-11-30 | Axcess Global Sciences, Llc | S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer |
| US10596130B2 (en) | 2017-12-19 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use |
| US20170266147A1 (en) * | 2016-03-18 | 2017-09-21 | Csilla Ari D'Agostino | Methods of increasing latency of anesthetic induction using ketone supplementation |
| US10925843B2 (en) | 2018-04-18 | 2021-02-23 | Axcess Global Sciences, Llc | Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate |
| US12622889B2 (en) | 2016-04-19 | 2026-05-12 | Axcess Global Sciences, Llc | S-β-hydroxybutyrate esters for improving metabolic function |
| US12496283B2 (en) | 2016-04-19 | 2025-12-16 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US11944598B2 (en) | 2017-12-19 | 2024-04-02 | Axcess Global Sciences, Llc | Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer |
| US12521378B2 (en) | 2016-04-19 | 2026-01-13 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans |
| US12533346B2 (en) | 2016-04-19 | 2026-01-27 | Axcess Global Sciences, Llc | Administration of berberine metabolites |
| US11806324B2 (en) | 2018-04-18 | 2023-11-07 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
| US11202769B2 (en) | 2017-11-22 | 2021-12-21 | Axcess Global Sciences, Llc | Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function |
| US20230346721A1 (en) | 2018-04-18 | 2023-11-02 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies |
| US12599579B2 (en) | 2016-04-19 | 2026-04-14 | Axcess Global Sciences, Llc | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids |
| US12329734B2 (en) | 2017-12-19 | 2025-06-17 | Axcess Global Sciences, Llc | Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow |
| US12109182B2 (en) * | 2016-04-19 | 2024-10-08 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US20180057846A1 (en) | 2016-08-30 | 2018-03-01 | KetoneAid Inc. | Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy |
| US11760963B2 (en) | 2017-08-23 | 2023-09-19 | KetoneAid Inc. | Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol |
| GB201616058D0 (en) * | 2016-09-21 | 2016-11-02 | Chain Biotechnology Ltd | Probiotic composition |
| US20180125812A1 (en) | 2016-11-04 | 2018-05-10 | Emory University | Dehydroacetic Acid (DHAA) and Derivative for Uses in Treating Cancer |
| US10376528B2 (en) | 2017-03-10 | 2019-08-13 | Tecton Group, Llc | Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor |
| WO2018187852A1 (en) * | 2017-04-12 | 2018-10-18 | Cavaleri Franco | Butyrate and beta-hydroxybutyrate compositions and methods of use thereof |
| CN107083406B (zh) * | 2017-05-27 | 2021-02-02 | 浙江华睿生物技术有限公司 | (r)-3-羟基丁酸的生产方法 |
| GB201710229D0 (en) | 2017-06-27 | 2017-08-09 | Tdeltas Ltd | Compounds for new use |
| JP6571298B2 (ja) * | 2017-08-18 | 2019-09-04 | 拓己 佐藤 | 血糖値スパイク抑制剤、食品及び血糖値スパイク抑制剤の製造方法 |
| GB201715654D0 (en) | 2017-09-27 | 2017-11-08 | Tdeltas Ltd | Method of treatment |
| US12090129B2 (en) | 2017-11-22 | 2024-09-17 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10512615B1 (en) | 2018-08-27 | 2019-12-24 | Axcess Global Sciences, Llc | Compositions and methods for delivering cannabidiol and ketone bodies |
| US10980772B2 (en) | 2018-08-27 | 2021-04-20 | Axcess Global Sciences, Llc | Compositions and methods for delivering tetrahydrocannabinol and ketone bodies |
| US11419836B2 (en) | 2019-02-13 | 2022-08-23 | Axcess Global Sciences, Llc | Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions |
| US11241401B2 (en) | 2020-02-06 | 2022-02-08 | Axcess Global Sciences, Llc | Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions |
| US11129802B2 (en) | 2018-08-27 | 2021-09-28 | Axcess Global Sciences, Llc | Compositions and methods for delivering cannabidiol and ketone bodies |
| EP3801496A4 (en) * | 2018-06-05 | 2022-07-06 | Flagship Pioneering Innovations V, Inc. | SUBSTANCES AND METHODS OF USE FOR THE TREATMENT OF METABOLIC DISEASES AND NON-ALCOHOL FATTY LIVER |
| GB2577723A (en) | 2018-10-04 | 2020-04-08 | Tdeltas Ltd | Compounds for new use |
| AU2020222897B2 (en) * | 2019-02-11 | 2025-08-14 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| JP2022520560A (ja) * | 2019-02-11 | 2022-03-31 | アクセス・グローバル・サイエンシーズ・エルエルシー | ベータ－ヒドロキシブチレート混合塩－酸組成物および使用方法 |
| CN109806251A (zh) * | 2019-03-04 | 2019-05-28 | 清华大学 | 3-羟基丁酸及其衍生物在制备抗动脉粥样硬化的产品中的应用 |
| US12472200B2 (en) | 2019-05-15 | 2025-11-18 | Axcess Global Sciences, Llc | Autobiotic compositions and method for promoting healthy gut microbiome |
| US12167993B2 (en) | 2019-06-21 | 2024-12-17 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US11950616B2 (en) | 2019-06-21 | 2024-04-09 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US11969430B1 (en) | 2023-03-10 | 2024-04-30 | Axcess Global Sciences, Llc | Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance |
| US11033553B2 (en) | 2019-06-21 | 2021-06-15 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| CN110776425B (zh) * | 2019-10-23 | 2021-02-26 | 清华大学 | 一种(r)-3-羟基丁酸及其低聚物的制备方法 |
| GB201918657D0 (en) | 2019-12-17 | 2020-01-29 | Tdeltas Ltd | Compounds for new use |
| WO2021195477A1 (en) | 2020-03-27 | 2021-09-30 | Ketoneaid, Inc. | Ketone ester as a therapeutic treatment of covid-19, long covid, and related viral infections |
| US12186297B2 (en) | 2020-08-26 | 2025-01-07 | Axcess Global Sciences, Llc | Compositions and methods for increasing lean-to-fat mass ratio |
| US20250275986A1 (en) * | 2021-07-17 | 2025-09-04 | Ketoswiss Ag | Combination of a ketone body or ketogenic compound with an analgesic or antioxidant |
| CN117919216A (zh) * | 2024-01-29 | 2024-04-26 | 中国药科大学 | 2-羟基-3-甲基丁酸在制备预防和/或治疗动脉粥样硬化的药物中的应用 |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU507322A1 (ru) | 1973-07-26 | 1976-03-25 | Московский Научно-Исследовательский Институт Косметологии | Регул тор гормонального обмена кожи |
| US3984566A (en) | 1974-02-25 | 1976-10-05 | Scott Eugene J Van | Method of alleviating the symptoms of dandruff |
| IT1051853B (it) | 1975-01-07 | 1981-05-20 | Basf Ag | Butandiol 1.3 3 mono 3 idros sibutirrati butandiol 1.3 1mono 3 idrossibutirrati e processi per la loro preparazione |
| US4380549A (en) | 1975-07-23 | 1983-04-19 | Scott Eugene J Van | Topical treatment of dry skin |
| JPS54138126A (en) | 1978-04-17 | 1979-10-26 | Ajinomoto Co Inc | Remedy for diabetes |
| AU6777487A (en) | 1985-12-18 | 1987-07-15 | Veech, R.L. | Parenteral nutrition therapy with amino acids |
| JPH0755158B2 (ja) | 1986-10-30 | 1995-06-14 | チッソ株式会社 | 光学活性エステルの製造法 |
| JP2579779B2 (ja) | 1987-10-08 | 1997-02-12 | 日本車輌製造株式会社 | 飼料の製造法 |
| BE1001209A3 (fr) | 1987-11-19 | 1989-08-22 | Solvay | Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol. |
| JPH0383950A (ja) | 1989-08-28 | 1991-04-09 | Kanegafuchi Chem Ind Co Ltd | グリセリド誘導体およびその製造法 |
| JP2873497B2 (ja) | 1990-09-03 | 1999-03-24 | 理化学研究所 | 脂質代謝調節剤 |
| JP2884123B2 (ja) | 1992-01-17 | 1999-04-19 | 高砂香料工業株式会社 | 生分解性光学活性ポリマー、その中間体オリゴマー、およびそれらの製造方法 |
| US5654266A (en) | 1992-02-10 | 1997-08-05 | Chen; Chung-Ho | Composition for tissues to sustain viability and biological functions in surgery and storage |
| US5281691A (en) | 1992-06-19 | 1994-01-25 | Eastman Kodak Company | Poly(3-hydroxyalkanoates) |
| JP3193542B2 (ja) | 1993-09-08 | 2001-07-30 | カネボウ株式会社 | 皮膚老化防止化粧料 |
| WO1995009144A1 (en) | 1993-09-30 | 1995-04-06 | Eastman Chemical Company | Nutritive water soluble glycerol esters of hydroxy butyric acid |
| EP0696605B1 (de) | 1994-08-10 | 2000-09-20 | Peter Neuenschwander | Biokompatibles Blockcopolymer |
| US6306828B1 (en) | 1995-04-06 | 2001-10-23 | Baxter International, Inc. | Enantiomerically-enhanced nutritional energy substrates |
| JP4598203B2 (ja) | 1995-12-01 | 2010-12-15 | ビーティージー・インターナショナル・リミテッド | 脳機能改善剤 |
| US6126953A (en) | 1996-08-19 | 2000-10-03 | The Procter & Gamble Company | Fragrance delivery systems for personal care articles |
| JPH10175855A (ja) | 1996-10-16 | 1998-06-30 | Taisho Pharmaceut Co Ltd | 肉体疲労改善剤 |
| US6316038B1 (en) | 1997-03-17 | 2001-11-13 | Btg International Limited | Therapeutic compositions |
| US6323237B1 (en) * | 1997-03-17 | 2001-11-27 | Btg International Limited | Therapeutic compositions |
| CN1315473C (zh) | 1997-03-17 | 2007-05-16 | 英国技术集团国际有限公司 | 治疗组合物 |
| US20090253781A1 (en) | 2002-05-24 | 2009-10-08 | Btg International Limited | Therapeutic compositions |
| JPH10265378A (ja) | 1997-03-25 | 1998-10-06 | Ofutekusu:Kk | 角膜上皮損傷治療剤 |
| WO1998051302A1 (en) | 1997-05-15 | 1998-11-19 | University Of Washington | Composition and methods for treating alzheimer's disease and other amyloidoses |
| US6727258B2 (en) | 1997-10-29 | 2004-04-27 | King Pharmaceutical Research & Development, Inc. | Allosteric adenosine receptor modulators |
| GB9723590D0 (en) | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
| CA2338090C (en) | 1998-07-22 | 2009-07-14 | Metabolix, Inc. | Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies |
| CA2339941A1 (en) | 1998-09-15 | 2000-03-23 | Btg International Limited | Use of cyclic esters of r-3-hydroxybutyrate for treatment of metabolic and neural degenerative disorders |
| WO2001013877A1 (en) | 1999-08-20 | 2001-03-01 | Unilever Plc | A method for reducing skin irritation and sting from weak carboxylic acid |
| BR0107626A (pt) | 2000-01-14 | 2002-10-15 | Genset Sa | Cabeças globulares de obg3 e usos destes para diminuir a massa corporal |
| ES2752800T3 (es) | 2000-05-01 | 2020-04-06 | Cerecin Inc | Uso de triglicéridos de cadena media para el tratamiento y la prevención de la enfermedad del Parkinson resultante de un metabolismo neuronal reducido |
| US8124589B2 (en) | 2000-05-01 | 2012-02-28 | Accera, Inc. | Use of ketogenic compounds for treatment of age-associated memory impairment |
| EP2275468A1 (en) | 2000-07-14 | 2011-01-19 | Metabolix, Inc. | Polyurethanes obtained from hydroxyalkanoates and isocyanates |
| AUPR177300A0 (en) | 2000-11-29 | 2000-12-21 | Centre For Molecular Biology And Medicine | Therapeutic methods |
| US20050129783A1 (en) | 2001-04-19 | 2005-06-16 | Mccleary Edward L. | Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health |
| DE20205184U1 (de) | 2002-03-27 | 2002-12-19 | Bartz, Volker, 35440 Linden | Blutfettsenker zur oralen Einnahme |
| CN1483355A (zh) | 2002-09-16 | 2004-03-24 | 岚 高 | 抗疲劳饮料配方 |
| ES2574918T3 (es) | 2003-06-02 | 2016-06-23 | Isis Innovation Limited | Tratamiento de la fatiga muscular |
| DK1648952T3 (da) | 2003-06-03 | 2018-05-28 | The Us Gov As Represented By The Department Of Health And Human Services | Kosttilskud og terapeutiske sammensætninger omfattende (R)-3-hydroxybutyrat-derivater |
| JP2005247821A (ja) | 2004-02-06 | 2005-09-15 | Ophtecs Corp | 炎症性サイトカインの産生を抑制するための眼科用組成物 |
| DE102004007029A1 (de) | 2004-02-12 | 2005-09-08 | Consortium für elektrochemische Industrie GmbH | Verfahren zur enantioselektiven Reduktion von Ketoverbindungen durch Enzyme |
| WO2006020137A2 (en) | 2004-07-16 | 2006-02-23 | Ketocytonyx Inc. | Oligomeric compounds |
| EP1778615A4 (en) * | 2004-07-20 | 2010-01-06 | Btg Int Ltd | OLIGOMERE KETONE COMPOUNDS |
| WO2006012490A2 (en) * | 2004-07-23 | 2006-02-02 | Ketocytonyx Inc. | Ketogenic saccharides |
| US8124063B2 (en) | 2004-10-25 | 2012-02-28 | Conopco, Inc. | Method for moisturizing human skin using dihydroxypropyltri(C1-C3 alkyl) ammonium salts |
| ITTO20040918A1 (it) | 2004-12-29 | 2005-03-29 | Luigi Ambrosio | Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione |
| WO2007001883A2 (en) | 2005-06-20 | 2007-01-04 | Accera, Inc. | Method to reduce oxidative damage and improve mitochondrial efficiency |
| JP5145240B2 (ja) | 2005-11-29 | 2013-02-13 | ビーエーエスエフ ソシエタス・ヨーロピア | ポリマー中の側鎖をエステル交換またはエステル化する方法 |
| JP2009534317A (ja) | 2006-04-12 | 2009-09-24 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 皮膚に対する抗老化効果を有する経口組成物 |
| WO2008005818A1 (en) | 2006-06-30 | 2008-01-10 | Stepan Co | Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose |
| JP5030553B2 (ja) | 2006-11-24 | 2012-09-19 | 有限会社ノーベル医学研究所 | ドライマウスおよび／または唾液分泌障害を処置するための医薬 |
| US20080253997A1 (en) | 2007-03-27 | 2008-10-16 | Perscitus Biosciences, Llc | Compositions and methods for protecting cells from toxic exposures |
| US20110003767A1 (en) | 2007-05-14 | 2011-01-06 | Neuera Pharmaceuticals, Inc. | Inhibitors of Acetyl-CoA Carboxylase for Treatment of Neuronal Hypometabolism |
| WO2009023357A2 (en) | 2007-05-25 | 2009-02-19 | University Of Rochester | Curcumin derivatives and their use as radioprotectors |
| WO2009089144A1 (en) | 2008-01-04 | 2009-07-16 | Isis Innovation Limited | Ketone bodies and ketone body esters as blood lipid lowering agents |
| ES2655367T3 (es) | 2008-08-21 | 2018-02-19 | Oxford University Innovation Limited | Bebida que comprende éster de hidroxibutirato y uso médico de la misma |
| US8642654B2 (en) | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| CN102449157B (zh) | 2009-04-16 | 2015-06-03 | 伊希斯创新有限公司 | 使用短乳杆菌醇脱氢酶通过酶促对映选择性还原来制备(3r)-羟丁基(3r)-羟基丁酸酯的方法 |
| GB201002983D0 (en) | 2010-02-22 | 2010-04-07 | Tdeltas Ltd | Nutritinal composition |
| FR2958154B1 (fr) | 2010-04-01 | 2012-06-08 | Oreal | Procede de soin et/ou de maquillage des rides |
| RU2013142256A (ru) | 2011-02-17 | 2015-03-27 | СиЭйчДи БАЙОСАЙЕНС, ИНК. | КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПЕРОКСИ-α-КЕТОКАРБОНОВУЮ КИСЛОТУ, И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ИСПОЛЬЗОВАНИЯ |
| WO2012113415A1 (en) | 2011-02-24 | 2012-08-30 | N.V. Nutricia | Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients |
| GB201206192D0 (en) | 2012-04-05 | 2012-05-23 | Tdeltas Ltd | Ketone bodies and ketone body esters and for maintaining or improving muscle power output |
| WO2014071389A1 (en) | 2012-11-05 | 2014-05-08 | Veech Richard L | Ketone bodies to protect tissues from damage by ionizing radiation |
| GB201304467D0 (en) | 2013-03-12 | 2013-04-24 | Tdeltas Ltd | Compound for use in protecting skin |
| GB2515603B (en) | 2013-03-14 | 2015-10-14 | Isis Innovation | Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate |
| GB201314127D0 (en) | 2013-08-07 | 2013-09-18 | Tdeltas Ltd | Ketone body and ketone body ester for reducing muscle breakdown |
-
2009
- 2009-01-05 WO PCT/US2009/030095 patent/WO2009089144A1/en not_active Ceased
- 2009-01-05 DK DK09701051.6T patent/DK2240017T3/da active
- 2009-01-05 CN CN201610322704.XA patent/CN106038532B/zh active Active
- 2009-01-05 EP EP09701051.6A patent/EP2240017B1/en active Active
- 2009-01-05 US US12/811,648 patent/US9211275B2/en active Active
- 2009-01-05 ES ES09701051T patent/ES2730879T3/es active Active
- 2009-01-05 CN CN2009801049582A patent/CN101969769A/zh active Pending
- 2009-01-05 TR TR2019/08522T patent/TR201908522T4/tr unknown
- 2009-01-05 AU AU2009204370A patent/AU2009204370B2/en not_active Ceased
-
2015
- 2015-11-03 US US14/931,265 patent/US10154982B2/en active Active
-
2018
- 2018-11-29 US US16/203,748 patent/US11311509B2/en active Active
-
2022
- 2022-04-25 US US17/728,600 patent/US12447140B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2240017A1 (en) | 2010-10-20 |
| US9211275B2 (en) | 2015-12-15 |
| CN106038532A (zh) | 2016-10-26 |
| US20160193173A1 (en) | 2016-07-07 |
| CN101969769A (zh) | 2011-02-09 |
| US12447140B2 (en) | 2025-10-21 |
| WO2009089144A1 (en) | 2009-07-16 |
| EP2240017B1 (en) | 2019-03-13 |
| AU2009204370B2 (en) | 2014-12-04 |
| US20190201366A1 (en) | 2019-07-04 |
| US20230075547A1 (en) | 2023-03-09 |
| US11311509B2 (en) | 2022-04-26 |
| CN106038532B (zh) | 2019-05-14 |
| US20100298294A1 (en) | 2010-11-25 |
| AU2009204370A1 (en) | 2009-07-16 |
| TR201908522T4 (tr) | 2019-07-22 |
| ES2730879T3 (es) | 2019-11-13 |
| US10154982B2 (en) | 2018-12-18 |
| EP2240017A4 (en) | 2011-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3311779C0 (en) | HEART VALVE | |
| EP2296593A4 (en) | MEDICAL HEAD COVER | |
| BRPI0910116A2 (pt) | desvio transparente e mecanismos associados | |
| DK1987765T3 (da) | Oximeter | |
| DK2240487T3 (da) | Triazolopyridaziner som para-inhibitorer, fremstilling og anvendelse heraf som lægemiddel | |
| DK2131682T3 (da) | Autoklave og fremgangsmåde | |
| UA18855S (uk) | Гіпертермотерапевтичне крісло | |
| DK2310037T3 (da) | Conglutin-gamma as-medikament og -kosttilskudpatentkrav | |
| FR2937843B1 (fr) | Paravent medical | |
| UA18696S (uk) | Браслет | |
| UY3831Q (es) | Pulsera | |
| TH97351B (th) | กำไล | |
| ITPR20080001A1 (it) | Divano | |
| UA18947S (uk) | Диван | |
| UA18872S (uk) | Диван | |
| UA18946S (uk) | Диван | |
| UA18325S (uk) | Диван | |
| UA17979S (uk) | Диван | |
| UA18871S (uk) | Диван | |
| UA17007S (uk) | Диван | |
| UA17242S (uk) | Диван | |
| UA14693S (uk) | Диван | |
| UA17149S (uk) | Диван | |
| TH99553B (th) | เก้าอี้ | |
| UA18941S (uk) | Крісло |